BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 31900488)

  • 1. Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.
    Ohi K; Nishizawa D; Shimada T; Kataoka Y; Hasegawa J; Shioiri T; Kawasaki Y; Hashimoto R; Ikeda K
    Int J Neuropsychopharmacol; 2020 Apr; 23(3):157-164. PubMed ID: 31900488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared transethnic genetic basis of panic disorder and psychiatric and related intermediate phenotypes.
    Ohi K; Otowa T; Shimada M; Sugiyama S; Muto Y; Tanahashi S; Kaiya H; Nishimura F; Sasaki T; Tanii H; Shioiri T
    Eur Neuropsychopharmacol; 2021 Jan; 42():87-96. PubMed ID: 33189524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eQTLs Weighted Genetic Correlation Analysis Detected Brain Region Differences in Genetic Correlations for Complex Psychiatric Disorders.
    Wen Y; Zhang F; Ma X; Fan Q; Wang W; Xu J; Zhu F; Hao J; He A; Liu L; Liang X; Du Y; Li P; Wu C; Wang S; Wang X; Ning Y; Guo X
    Schizophr Bull; 2019 Apr; 45(3):709-715. PubMed ID: 29912442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
    Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
    Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
    Ikeda M; Takahashi A; Kamatani Y; Momozawa Y; Saito T; Kondo K; Shimasaki A; Kawase K; Sakusabe T; Iwayama Y; Toyota T; Wakuda T; Kikuchi M; Kanahara N; Yamamori H; Yasuda Y; Watanabe Y; Hoya S; Aleksic B; Kushima I; Arai H; Takaki M; Hattori K; Kunugi H; Okahisa Y; Ohnuma T; Ozaki N; Someya T; Hashimoto R; Yoshikawa T; Kubo M; Iwata N
    Schizophr Bull; 2019 Jun; 45(4):824-834. PubMed ID: 30285260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank.
    Leppert B; Millard LAC; Riglin L; Davey Smith G; Thapar A; Tilling K; Walton E; Stergiakouli E
    PLoS Genet; 2020 May; 16(5):e1008185. PubMed ID: 32392212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared polygenic risk for ADHD, executive dysfunction and other psychiatric disorders.
    Chang S; Yang L; Wang Y; Faraone SV
    Transl Psychiatry; 2020 Jun; 10(1):182. PubMed ID: 32518222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample.
    Jansen AG; Dieleman GC; Jansen PR; Verhulst FC; Posthuma D; Polderman TJC
    Behav Genet; 2020 Jul; 50(4):203-212. PubMed ID: 31346826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and psychosocial influence on the association between early childhood infections and later psychiatric disorders.
    Debost JPG; Thorsteinsson E; Trabjerg B; Benros ME; Albiñana C; Vilhjalmsson BJ; Børglum A; Mors O; Werge T; Mortensen PB; Agerbo E; Petersen LV
    Acta Psychiatr Scand; 2022 Nov; 146(5):406-419. PubMed ID: 35999619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk and coaggregation of major psychiatric disorders among first-degree relatives of patients with bipolar disorder: a nationwide population-based study.
    Chen MH; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Cheng CM; Chang WH; Pan TL; Chen TJ; Bai YM
    Psychol Med; 2019 Oct; 49(14):2397-2404. PubMed ID: 30415649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic Risk Scores Differentiating Schizophrenia From Bipolar Disorder Are Associated With Premorbid Intelligence in Schizophrenia Patients and Healthy Subjects.
    Ohi K; Nishizawa D; Sugiyama S; Takai K; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
    Int J Neuropsychopharmacol; 2021 Jul; 24(7):562-569. PubMed ID: 33738471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations Between Symptoms of Premenstrual Disorders and Polygenic Liability for Major Psychiatric Disorders.
    Jaholkowski P; Shadrin AA; Jangmo A; Frei E; Tesfaye M; Hindley GFL; Haram M; Rahman Z; Athanasiu L; Bakken NR; Holen B; Fominykh V; Kutrolli G; Parekh P; Parker N; Rødevand L; Birkenæs V; Djurovic S; Frei O; O'Connell KS; Smeland OB; Tesli M; Andreassen OA
    JAMA Psychiatry; 2023 Jul; 80(7):738-742. PubMed ID: 37163253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures.
    Leppert B; Havdahl A; Riglin L; Jones HJ; Zheng J; Davey Smith G; Tilling K; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
    JAMA Psychiatry; 2019 Aug; 76(8):834-842. PubMed ID: 31042271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coaggregation of Major Psychiatric Disorders in First-Degree Relatives of Individuals With Attention-Deficit/Hyperactivity Disorder: A Nationwide Population-Based Study.
    Chen MH; Pan TL; Huang KL; Hsu JW; Bai YM; Su TP; Li CT; Tsai SJ; Cheng CM; Chen TJ
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 31090279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
    Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores for major psychiatric and neurodevelopmental disorders contribute to sleep disturbance in childhood: Adolescent Brain Cognitive Development (ABCD) Study.
    Ohi K; Ochi R; Noda Y; Wada M; Sugiyama S; Nishi A; Shioiri T; Mimura M; Nakajima S
    Transl Psychiatry; 2021 Mar; 11(1):187. PubMed ID: 33771979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EXPLORATORY ANALYSIS OF POLYGENIC RISK SCORES FOR PSYCHIATRIC DISORDERS: APPLIED TO DUAL DIAGNOSIS.
    Martínez-Magaña JJ; Gonzalez-Castro TB; Genís-Mendoza AD; Tovilla-Zárate CA; Juárez-Rojop IE; Saucedo-Uribe E; Rodríguez-Mayoral O; Lanzagorta N; Escamilla M; Macías-Kauffer L; Nicolini H
    Rev Invest Clin; 2019; 71(5):321-329. PubMed ID: 31599879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polygenic risk scores for late smoking initiation associated with the risk of schizophrenia.
    Ohi K; Nishizawa D; Muto Y; Sugiyama S; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Shioiri T; Ikeda K
    NPJ Schizophr; 2020 Nov; 6(1):36. PubMed ID: 33230172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic risk score for five major psychiatric disorders associated with volume of distinct brain regions in the general population.
    Wang Z; Liu C; Dong Q; Xue G; Chen C
    Biol Psychol; 2023 Mar; 178():108530. PubMed ID: 36858107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.
    Witt SH; Streit F; Jungkunz M; Frank J; Awasthi S; Reinbold CS; Treutlein J; Degenhardt F; Forstner AJ; Heilmann-Heimbach S; Dietl L; Schwarze CE; Schendel D; Strohmaier J; Abdellaoui A; Adolfsson R; Air TM; Akil H; Alda M; Alliey-Rodriguez N; Andreassen OA; Babadjanova G; Bass NJ; Bauer M; Baune BT; Bellivier F; Bergen S; Bethell A; Biernacka JM; Blackwood DHR; Boks MP; Boomsma DI; Børglum AD; Borrmann-Hassenbach M; Brennan P; Budde M; Buttenschøn HN; Byrne EM; Cervantes P; Clarke TK; Craddock N; Cruceanu C; Curtis D; Czerski PM; Dannlowski U; Davis T; de Geus EJC; Di Florio A; Djurovic S; Domenici E; Edenberg HJ; Etain B; Fischer SB; Forty L; Fraser C; Frye MA; Fullerton JM; Gade K; Gershon ES; Giegling I; Gordon SD; Gordon-Smith K; Grabe HJ; Green EK; Greenwood TA; Grigoroiu-Serbanescu M; Guzman-Parra J; Hall LS; Hamshere M; Hauser J; Hautzinger M; Heilbronner U; Herms S; Hitturlingappa S; Hoffmann P; Holmans P; Hottenga JJ; Jamain S; Jones I; Jones LA; Juréus A; Kahn RS; Kammerer-Ciernioch J; Kirov G; Kittel-Schneider S; Kloiber S; Knott SV; Kogevinas M; Landén M; Leber M; Leboyer M; Li QS; Lissowska J; Lucae S; Martin NG; Mayoral-Cleries F; McElroy SL; McIntosh AM; McKay JD; McQuillin A; Medland SE; Middeldorp CM; Milaneschi Y; Mitchell PB; Montgomery GW; Morken G; Mors O; Mühleisen TW; Müller-Myhsok B; Myers RM; Nievergelt CM; Nurnberger JI; O'Donovan MC; Loohuis LMO; Ophoff R; Oruc L; Owen MJ; Paciga SA; Penninx BWJH; Perry A; Pfennig A; Potash JB; Preisig M; Reif A; Rivas F; Rouleau GA; Schofield PR; Schulze TG; Schwarz M; Scott L; Sinnamon GCB; Stahl EA; Strauss J; Turecki G; Van der Auwera S; Vedder H; Vincent JB; Willemsen G; Witt CC; Wray NR; Xi HS; ; ; ; Tadic A; Dahmen N; Schott BH; Cichon S; Nöthen MM; Ripke S; Mobascher A; Rujescu D; Lieb K; Roepke S; Schmahl C; Bohus M; Rietschel M
    Transl Psychiatry; 2017 Jun; 7(6):e1155. PubMed ID: 28632202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.